Tag: Phase 2b/3 clinical study

July 17, 2019

Seelos Therapeutics Submits Investigational New Drug Application for SLS-005

Seelos Therapeutics (NASDAQ:SEEL) has announced it has submitted an investigational new drug application to the US Food and Drug Administration...